Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Needle-free jet injection of rapid-acting insulin improves early postprandial glucose control in patients with diabetes.

Engwerda EE, Tack CJ, de Galan BE.

Diabetes Care. 2013 Nov;36(11):3436-41. doi: 10.2337/dc13-0492. Epub 2013 Oct 2.

PMID:
24089542
[PubMed - in process]
Free PMC Article
2.

Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology.

Engwerda EE, Abbink EJ, Tack CJ, de Galan BE.

Diabetes Care. 2011 Aug;34(8):1804-8. doi: 10.2337/dc11-0182. Epub 2011 Jun 29.

PMID:
21715522
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.

Rosenfalck AM, Thorsby P, Kjems L, Birkeland K, Dejgaard A, Hanssen KF, Madsbad S.

Acta Diabetol. 2000 Mar;37(1):41-6.

PMID:
10928235
[PubMed - indexed for MEDLINE]
4.

Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

Diabetes Care. 2002 Dec;25(12):2147-52.

PMID:
12453952
[PubMed - indexed for MEDLINE]
5.

Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.

Malone JK, Woodworth JR, Arora V, Yang H, Campaigne BN, Hallé JP, Yale JF, Grossman LD.

Clin Ther. 2000 Feb;22(2):222-30.

PMID:
10743981
[PubMed - indexed for MEDLINE]
6.

Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.

Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B.

Clin Ther. 2009 May;31(5):980-7. doi: 10.1016/j.clinthera.2009.05.010.

PMID:
19539098
[PubMed - indexed for MEDLINE]
7.

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.

Lindholm A, McEwen J, Riis AP.

Diabetes Care. 1999 May;22(5):801-5.

PMID:
10332685
[PubMed - indexed for MEDLINE]
Free Article
9.

Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.

Jovanovic L, Giammattei J, Acquistapace M, Bornstein K, Sommermann E, Pettitt DJ.

Clin Ther. 2004 Sep;26(9):1492-7.

PMID:
15531011
[PubMed - indexed for MEDLINE]
10.

Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.

Feinglos MN, Thacker CH, English J, Bethel MA, Lane JD.

Diabetes Care. 1997 Oct;20(10):1539-42.

PMID:
9314631
[PubMed - indexed for MEDLINE]
11.

Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

Weyer C, Gottlieb A, Kim DD, Lutz K, Schwartz S, Gutierrez M, Wang Y, Ruggles JA, Kolterman OG, Maggs DG.

Diabetes Care. 2003 Nov;26(11):3074-9.

PMID:
14578242
[PubMed - indexed for MEDLINE]
12.

Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.

Rassam AG, Zeise TM, Burge MR, Schade DS.

Diabetes Care. 1999 Jan;22(1):133-6.

PMID:
10333914
[PubMed - indexed for MEDLINE]
Free Article
13.

A pilot study to examine the tolerability and device preference in type 1 diabetes of insulin aspart administered by InsuJet compared with subcutaneous injection.

Reutens AT, Balkau B, Cohen N.

Diabetes Technol Ther. 2014 Apr;16(4):235-40. doi: 10.1089/dia.2013.0250. Epub 2013 Nov 28.

PMID:
24286115
[PubMed - indexed for MEDLINE]
14.

Targeting postprandial hyperglycaemia in patients with recently diagnosed type 2 diabetes with a fixed, weight-based dose of insulin Aspart.

Gredal C, Rosenfalck AM, Dejgaard A, Hilsted J.

Scand J Clin Lab Invest. 2008;68(8):739-44. doi: 10.1080/00365510802207982.

PMID:
19016075
[PubMed - indexed for MEDLINE]
15.

Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

Rom J Intern Med. 2003;41(2):153-62.

PMID:
15526500
[PubMed - indexed for MEDLINE]
16.

Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.

Hermansen K, Colombo M, Storgaard H, ØStergaard A, Kølendorf K, Madsbad S.

Diabetes Care. 2002 May;25(5):883-8.

PMID:
11978685
[PubMed - indexed for MEDLINE]
17.

Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.

Linnebjerg H, Kothare PA, Skrivanek Z, de la Peña A, Atkins M, Ernest CS, Trautmann ME.

Diabet Med. 2006 Mar;23(3):240-5.

PMID:
16492205
[PubMed - indexed for MEDLINE]
18.

A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.

Plank J, Wutte A, Brunner G, Siebenhofer A, Semlitsch B, Sommer R, Hirschberger S, Pieber TR.

Diabetes Care. 2002 Nov;25(11):2053-7.

PMID:
12401756
[PubMed - indexed for MEDLINE]
19.

Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients.

Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Bates PC, Birkett MA.

Diabetes Care. 1998 Apr;21(4):570-3.

PMID:
9571344
[PubMed - indexed for MEDLINE]
20.

Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.

Luijf YM, van Bon AC, Hoekstra JB, Devries JH.

Diabetes Care. 2010 Oct;33(10):2152-5. doi: 10.2337/dc10-0692. Epub 2010 Aug 6.

PMID:
20693354
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk